Showing codes Q5118 (Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg) — Q9958 (High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml)

Q5118 - Inj., zirabev, 10 mg
Long description: Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg
Code added date: 20191001.
Code effective date: 20191001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5119 - Inj ruxience, 10 mg
Long description: Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg
Code added date: 20200701.
Code effective date: 20200701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5120 - Inj pegfilgrastim-bmez 0.5mg
Long description: Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg
Code added date: 20200701.
Code effective date: 20230401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5121 - Inj. avsola, 10 mg
Long description: Injection, infliximab-axxq, biosimilar, (avsola), 10 mg
Code added date: 20200701.
Code effective date: 20231001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5122 - Inj, nyvepria
Long description: Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg
Code added date: 20210101.
Code effective date: 20230401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5123 - Inj. riabni, 10 mg
Long description: Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
Code added date: 20210701.
Code effective date: 20210701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5124 - Inj. byooviz, 0.1 mg
Long description: Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg
Code added date: 20220401.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5125 - Inj, releuko 1 mcg
Long description: Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
Code added date: 20221001.
Code effective date: 20221001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5126 - Inj alymsys 10 mg
Long description: Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
Code added date: 20230101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5127 - Inj, stimufend, 0.5 mg
Long description: Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg
Code added date: 20230401.
Code effective date: 20230401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5128 - Inj, cimerli, 0.1 mg
Long description: Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg
Code added date: 20230401.
Code effective date: 20230401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5129 - Inj, vegzelma, 10 mg
Long description: Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg
Code added date: 20230401.
Code effective date: 20230701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5130 - Inj, fylnetra, 0.5 mg
Long description: Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg
Code added date: 20230401.
Code effective date: 20230401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5131 - Inj, idacio, 20 mg
Long description: Injection, adalimumab-aacf (idacio), biosimilar, 20 mg
Code added date: 20230701.
Code effective date: 20230701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5132 - Inj, abrilada, 10 mg
Long description: Injection, adalimumab-afzb (abrilada), biosimilar, 10 mg
Code added date: 20240101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q6 - Fee/time comp subst md or pt
Long description: Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area
Code added date: 19930101.
Code effective date: 20170701.
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q7 - One class a finding
Long description: One class a finding
Code added date: 19950101.
Code effective date: 19970101.
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q8 - Two class b findings
Long description: Two class b findings
Code added date: 19950101.
Code effective date: 19970101.
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9 - 1 class b & 2 class c fndngs
Long description: One class b and two class c findings
Code added date: 19950101.
Code effective date: 19970101.
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9001 - Chaplain assessment
Long description: Assessment by chaplain services
Code added date: 20201001.
Code effective date: 20221001.
Pricing Indicator Code(s): 99 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9002 - Chaplain counsel individu
Long description: Counseling, individual, by chaplain services
Code added date: 20201001.
Code effective date: 20221001.
Pricing Indicator Code(s): 99 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9003 - Chaplain counsel group
Long description: Counseling, group, by chaplain services
Code added date: 20201001.
Code effective date: 20221001.
Pricing Indicator Code(s): 99 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9004 - Va whole health partner serv
Long description: Department of veterans affairs whole health partner services
Code added date: 20211001.
Code effective date: 20211001.
Pricing Indicator Code(s): 99 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9950 - Inj sulf hexa lipid microsph
Long description: Injection, sulfur hexafluoride lipid microspheres, per ml
Code added date: 20160101.
Code effective date: 20240101.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9951 - Locm >= 400 mg/ml iodine,1ml
Long description: Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
Code added date: 20050401.
Code effective date: 20050401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9953 - Inj fe-based mr contrast,1ml
Long description: Injection, iron-based magnetic resonance contrast agent, per ml
Code added date: 20050401.
Code effective date: 20050401.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9954 - Oral mr contrast, 100 ml
Long description: Oral magnetic resonance contrast agent, per 100 ml
Code added date: 20050401.
Code effective date: 20050401.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9955 - Inj perflexane lip micros,ml
Long description: Injection, perflexane lipid microspheres, per ml
Code added date: 20050401.
Code effective date: 20050401.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9956 - Inj octafluoropropane mic,ml
Long description: Injection, octafluoropropane microspheres, per ml
Code added date: 20050401.
Code effective date: 20050401.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9957 - Inj perflutren lip micros,ml
Long description: Injection, perflutren lipid microspheres, per ml
Code added date: 20050401.
Code effective date: 20050401.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9958 - Hocm <=149 mg/ml iodine, 1ml
Long description: High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
Code added date: 20050701.
Code effective date: 20050701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF